BJDX - Bluejay Diagnostics, Inc.

7.5
3.970   52.933%

Share volume: 58,463,509
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$3.53
3.97
1.12%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
18%
Profitability 0%
Dept financing 12%
Liquidity 53%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
130.77%
1 Month
80.72%
3 Months
113.68%
6 Months
6,304.78%
1 Year
1,071.88%
2 Year
153.38%
Key data
Stock price
$7.50
P/E Ratio 
0.00
DAY RANGE
$6.94 - $10.20
EPS 
-$8.37
52 WEEK RANGE
$0.07 - $10.20
52 WEEK CHANGE
$1,111.63
MARKET CAP 
1.214 M
YIELD 
N/A
SHARES OUTSTANDING 
12.854 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
2.97
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,013,518
AVERAGE 30 VOLUME 
$2,887,709
Company detail
CEO: Indranil Dey
Region: US
Website: bluejaydx.com
Employees: 9
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.

Recent news
loading